Stealthy oncology co raised big. Nuvation Bio announced a $275M mega round from top investors, such as Omega Funds, Aisling Capital, and Perceptive Advisors. The upstart tapped David Hung as the CEO, who sold Medivation to Pfizer at a $14B enterprise value.
In league with the big HR tech. Health benefits platform LEAGUE (a member of our inaugural Digital Health 150) announced a strategic investment from HR tech giant Workday. The company will integrate its Health Benefits Experience platform into Workday.
A new public fertility co was born. Fertility benefit provider Progyny opened trading last Friday on NASDAQ, stock is up 26% since opening. Progyny’s founder now leads a new fertility co Kindbody.
Instrument-free is all the rage. Sense Bio raised £12.3M to develop an “instrument-free” diagnostics test that can be performed at the point of care. Cambridge Innovation Capital and Earlybird co-led. Sherlock Biosciences announced a partnership to develop similar technology as well.
Trusting your AI docs. As consumer-facing health apps like Flo & Clue venture into risk assessment for anxiety-inducing issues like PCOS, users and experts question if they add value.
New York Times
Socialized medicine? The jury is still out on whether social media leads to mental health issues. WSJ highlights how psychologists are prescribing social media as a way to combat anxiety.
A cancer drug’s journey. Bradley Fikes & John Wilkens illustrate the ups & downs of a cancer drug throughout the years — proving how challenging this effort is, especially for cancer patients.
The San Diego Union-Tribune